当前位置: X-MOL 学术Acc. Chem. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bioactive Peptide Natural Products as Lead Structures for Medicinal Use
Accounts of Chemical Research ( IF 16.4 ) Pub Date : 2017-06-26 00:00:00 , DOI: 10.1021/acs.accounts.7b00159
Tam Dang 1 , Roderich D. Süssmuth 1
Affiliation  

The need for new drugs for the treatment of various diseases is enormous. From the previous century until the present, numerous peptide and peptide-derived natural products have been isolated from bacteria and fungi. Hence, microorganisms play a pivotal role as sources for novel drugs with an emphasis on anti-infective agents. Various disciplines from biology, chemistry, and medicine are involved in early stages of the search for peptide natural products including taxonomy, microbiology, bioanalytics, bioinformatics, and medicinal chemistry. Under biochemical aspects, small peptide drugs are basically either ribosomally synthesized and post-translationally modified (RiPPs) or synthesized by multimodular nonribosomal peptide synthetases (NRPSs).

中文翻译:

生物活性肽天然产物作为药用铅结构

对于治疗各种疾病的新药的需求是巨大的。从上个世纪到现在,已经从细菌和真菌中分离出许多肽和肽衍生的天然产物。因此,微生物作为新药的来源起着举足轻重的作用,重点是抗感染剂。搜寻肽天然产物的早期阶段涉及生物学,化学和医学等各个学科,包括分类学,微生物学,生物分析,生物信息学和药物化学。在生化方面,小肽药物基本上是通过核糖体合成和翻译后修饰(RiPPs)或通过多模块非核糖体肽合成酶(NRPS)合成的。
更新日期:2017-06-26
down
wechat
bug